Skip to content
MedsAcross

Medicine

Ritonavir 100 mg tablet

Ritonavir · Oral
Available on requestPrescription onlyUS FDAGeneric name

Ritonavir 100 mg tablet is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at or below 30°C (86°F). Exposure to temperatures up to 50°C (122°F) for…

Key facts

Active ingredient (INN)
Ritonavir
Brand
Sold under the generic name
Strength
100 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 30 tablets and 11 more
Manufacturers
Aurobindo PharmaIndiaCamber PharmaceuticalsIndiaCiplaIndiaAmneal PharmaceuticalsBryant Ranch PrepackAmerican Health PackagingNuCare Pharmaceuticals,Inc
Origin register
US FDA, United States
Storage
Store at or below 30°C (86°F). Exposure to temperatures up to 50°C (122°F) for seven days permitted.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J05AE03 Ritonavir
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
17 September 2018
Identifiers
RxCUI 900575DailyMed set ID 3c811e3e-f685-4af7-a4d1-037f2613ee68, 4633c6ba-168d-426f-acae-7843e167743a, 3f92f1e2-59f4-f6c4-e063-6294a90a487b +5NDC 63629-5702, 69097-655, 68071-3898 +5Application ANDA204587, ANDA202573, ANDA206614 +1

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet, film coated in 1 bottle65862-687-01Aurobindo PharmaIndia17 September 2018
500 tablet, film coated in 1 bottle65862-687-05Aurobindo PharmaIndia17 September 2018
30 tablet, film coated in 1 bottle65862-687-30Aurobindo PharmaIndia17 September 2018
1000 tablet, film coated in 1 bottle65862-687-99Aurobindo PharmaIndia17 September 2018
120 tablet in 1 bottle31722-597-12Camber PharmaceuticalsIndia17 September 2018
30 tablet in 1 bottle31722-597-30Camber PharmaceuticalsIndia17 September 2018
30 tablet in 1 container69097-655-02CiplaIndia23 March 2022
120 tablet in 1 container69097-655-08CiplaIndia23 March 2022
60 tablet in 1 bottle65162-061-06Amneal Pharmaceuticals21 September 2018
360 tablet in 1 bottle65162-061-32Amneal Pharmaceuticals21 September 2018
15 tablet in 1 bottle63629-5702-1Bryant Ranch Prepack5 June 2025
15 tablet, film coated in 1 bottle71335-2610-1Bryant Ranch Prepack11 March 2026
30 blister pack in 1 box, unit-dose / 1 tablet, film coated in 1 blister pack60687-420-25American Health Packaging27 December 2018
3 tablet, film coated in 1 bottle68071-3898-3NuCare Pharmaceuticals24 September 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 1 March 1996Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Ritonavir 100 mg tablet.

Compare 1

Other strengths and forms of Ritonavir

Clinical summary

Ritonavir is a cytochrome P450 3A inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection, among other approved uses. It is available as tablets and oral powder. MedsAcross supplies Ritonavir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Ritonavir

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ritonavir 100 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.